INNOSCIENCE (02577) Income Statement & Earnings

48.000
-1.260-2.56%

15min DelayMarket Closed Jul 16 16:07 CST

43.92BMarket Cap-47.20P/E (TTM)

INNOSCIENCE (02577) Income Statement

Cumulative·All

YOY

Hide blank lines

Currency: CNY

2025/FY

2025/H1

2024/FY

2024/H1

2023/FY

2023/H1

2022/FY

2021/FY

Total Revenue

+46.45%1.21B

+43.43%553.35M

+39.77%828.46M

+25.22%385.81M

+335.26%592.72M

--308.11M

+99.62%136.17M

--68.22M

Operating Revenue

+46.45%1.21B

+43.43%553.35M

+39.77%828.46M

+25.22%385.81M

+335.26%592.72M

--308.11M

+99.62%136.17M

--68.22M

Cost of Revenue

-13.60%-1.12B

-9.90%-515.51M

-3.68%-989.88M

+13.58%-469.05M

-80.05%-954.79M

---542.76M

-112.33%-530.28M

---249.75M

Cost of Goods Sold

-13.60%-1.12B

-9.90%-515.51M

-3.68%-989.88M

+13.58%-469.05M

-80.05%-954.79M

---542.76M

-112.33%-530.28M

---249.75M

Gross Profit

+154.99%88.76M

+145.47%37.85M

+55.42%-161.42M

+64.52%-83.24M

+8.13%-362.07M

---234.64M

-117.10%-394.11M

---181.53M

Operating Expense

-9.46%-954.61M

-15.97%-461.71M

-27.14%-872.09M

-31.98%-398.12M

+19.27%-685.91M

---301.65M

+2.25%-849.64M

---869.23M

Selling Expenses

-12.32%-109.97M

-6.37%-53.88M

-8.67%-97.91M

-12.95%-50.65M

-29.98%-90.10M

---44.84M

-143.78%-69.32M

---28.43M

Administrative Expenses

-4.26%-470.40M

-21.53%-245.51M

-82.61%-451.16M

-127.18%-202.02M

-24.01%-247.07M

---88.92M

-11.24%-199.23M

---179.10M

Research and Development Expenses

-15.85%-374.24M

-11.60%-162.33M

+7.38%-323.03M

+13.36%-145.45M

+39.98%-348.75M

---167.88M

+12.18%-581.09M

---661.70M

Special Items of Operating Income

+56.58%113.10M

+27.41%47.97M

+11.19%72.23M

+93.98%37.65M

-4.41%64.96M

--19.41M

+56.03%67.96M

--43.56M

Operating Profit

+21.69%-752.74M

+15.28%-375.90M

+2.21%-961.28M

+14.16%-443.71M

+16.39%-983.02M

---516.88M

-16.74%-1.18B

---1.01B

Financing Cost

-3.80%-87.26M

-19.00%-52.51M

+29.30%-84.07M

+29.75%-44.12M

+88.45%-118.91M

---62.81M

+56.96%-1.03B

---2.39B

Pretax Profit

+19.64%-840.00M

+12.18%-428.41M

+5.14%-1.05B

+15.85%-487.83M

+50.04%-1.10B

---579.70M

+35.12%-2.21B

---3.40B

Tax

-53.43%-514.00K

-57.40%-266.00K

-2292.86%-335.00K

---169.00K

+79.10%-14.00K

----

---67.00K

----

Net Profit

+19.62%-840.51M

+12.16%-428.67M

+5.11%-1.05B

+15.82%-488.00M

+50.04%-1.10B

---579.70M

+35.12%-2.21B

---3.40B

Profit from Continuing Operations

+19.62%-840.51M

+12.16%-428.67M

+5.11%-1.05B

+15.82%-488.00M

+50.04%-1.10B

---579.70M

+35.12%-2.21B

---3.40B

Net Income to Parent Company

+19.62%-840.51M

+12.16%-428.67M

+5.11%-1.05B

+15.82%-488.00M

+50.04%-1.10B

---579.70M

+35.12%-2.21B

---3.40B

Net Income to Common Stockholders

+19.62%-840.51M

+12.16%-428.67M

+5.11%-1.05B

+15.82%-488.00M

+50.04%-1.10B

---579.70M

+35.12%-2.21B

---3.40B

Basic EPS

+25.78%-0.95

+18.33%-0.49

+7.25%-1.28

---0.60

---1.38

----

Diluted EPS

+25.78%-0.95

+18.33%-0.49

+7.25%-1.28

---0.60

---1.38

----

Deadline

Dec 31, 2025

Jun 30, 2025

Dec 31, 2024

Jun 30, 2024

Dec 31, 2023

Jun 30, 2023

Dec 31, 2022

Dec 31, 2021

Accounting Standard

HKAS

Audit Opinions

	2025/FY	2025/H1	2024/FY	2024/H1	2023/FY	2023/H1	2022/FY	2021/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"